|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.140 EUR | 0.00% |
|
-3.39% | -22.45% |
| Jul. 06 | Laboratorio Erfo continues buyback, acquires 15,000 treasury shares | AN |
| Jun. 29 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 3.95M | 4.74M | 4.62M | 7.86M |
Direct | 598K | 500K | 703K | 850K | 1.09M |
Other | - | 457K | 576K | 562K | 672K |
Medical | - | 125K | 244K | 306K | 411K |
Revenues from Services | 1.12K | - | - | - | - |
Wholesale Sales Revenues | 4.07M | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 4.66M | 5.01M | 5.23M | 5.33M | 8.96M |
France | - | - | 797K | 852K | 898K |
Belgium | - | - | 228K | 157K | 176K |
Other (EU) | - | - | 5K | - | - |
Spain | 8K | 15.4K | 5.17K | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 2012-12-31 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 2012-12-31 |
Flavio Corpina
BRD | Director/Board Member | 47 | 2016-12-31 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -3.39% | -8.80% | +16.33% | 11.04M | ||
| +0.86% | +1.43% | +48.50% | +160.39% | 1,057B | ||
| +1.59% | +4.09% | +55.34% | +53.96% | 624B | ||
| +0.95% | +1.91% | +35.91% | +81.14% | 454B | ||
| +1.60% | +6.25% | +33.95% | +29.84% | 341B | ||
| -0.60% | +1.52% | +35.68% | +39.76% | 297B | ||
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | ||
| +0.09% | -2.82% | -28.29% | -41.71% | 215B | ||
| +1.22% | +2.66% | +21.87% | +59.73% | 201B | ||
| -1.18% | -3.70% | +14.23% | +66.51% | 162B | ||
| Average | +0.33% | +0.63% | +22.46% | +48.35% | 361.4B | |
| Weighted average by Cap. | +0.54% | +1.92% | +35.73% | +77.61% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















